IC
IEQ Capital Portfolio holdings
AUM
$16.3B
1-Year Return
39.51%
This Quarter Return
-4.15%
1 Year Return
+39.51%
3 Year Return
+152.4%
5 Year Return
+193.99%
10 Year Return
–
AUM
$12.6B
AUM Growth
+$2.23B
(+22%)
Cap. Flow
+$2.8B
Cap. Flow
% of AUM
22.27%
Top 10 Holdings %
Top 10 Hldgs %
34.58%
Holding
1,766
New
441
Increased
782
Reduced
314
Closed
159
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$165M |
| 2 |
Roblox
RBLX
|
+$134M |
| 3 |
Apple
AAPL
|
+$115M |
| 4 |
Vanguard Total Stock Market ETF
VTI
|
+$107M |
| 5 |
Meta Platforms (Facebook)
META
|
+$94.9M |
Top Sells
| 1 |
Twilio
TWLO
|
+$30.5M |
| 2 |
Goldman Sachs
GS
|
+$27.7M |
| 3 |
SMAR
Smartsheet Inc.
SMAR
|
+$13.4M |
| 4 |
HCP
HashiCorp, Inc. Class A Common Stock
HCP
|
+$10.7M |
| 5 |
AppFolio
APPF
|
+$5.61M |
Sector Composition
| 1 | Technology | 22.27% |
| 2 | Communication Services | 17.89% |
| 3 | Financials | 10.61% |
| 4 | Consumer Discretionary | 7.51% |
| 5 | Healthcare | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1526
Prime Medicine
PRME
$726M
| $69.4K | ﹤0.01% |
+34,882
| New | +$69.4K |
|
1527
Rayonier Advanced Materials
RYAM
$421M
| $69.3K | ﹤0.01% |
12,057
+2,003
| +20% | +$11.5K |
|
1528
Standard BioTools
LAB
$493M
| $68.2K | ﹤0.01% |
+63,182
| New | +$68.2K |
|
1529
Beyond Meat
BYND
$205M
| $67.3K | ﹤0.01% |
+22,055
| New | +$67.3K |
|
1530
Nordic American Tanker
NAT
$669M
| $66.6K | ﹤0.01% |
+27,090
| New | +$66.6K |
|
1531
LG Display
LPL
$4.46B
| $64.8K | ﹤0.01% |
+20,831
| New | +$64.8K |
|
1532
Itaú Unibanco
ITUB
$75B
| $63.9K | ﹤0.01% |
+11,620
| New | +$63.9K |
|
|
CLPR
1533
Clipper Realty
CLPR
$70.6M
| $63.1K | ﹤0.01% |
16,423
-12,745
| -44% | -$48.9K |
|
|
RCS
1534
PIMCO Strategic Income Fund
RCS
$342M
| $63K | ﹤0.01% |
+10,082
| New | +$63K |
|
1535
Granite Ridge Resources
GRNT
$705M
| $61.9K | ﹤0.01% |
+10,189
| New | +$61.9K |
|
|
RC
1536
Ready Capital
RC
$689M
| $61.5K | ﹤0.01% |
12,085
-2,423
| -17% | -$12.3K |
|
1537
Coherus Oncology, Inc. Common Stock
CHRS
$150M
| $60.5K | ﹤0.01% |
75,020
+25,837
| +53% | +$20.9K |
|
1538
Fate Therapeutics
FATE
$111M
| $58.9K | ﹤0.01% |
+74,506
| New | +$58.9K |
|
1539
Gannett
GCI
$620M
| $58.2K | ﹤0.01% |
20,150
+9,493
| +89% | +$27.4K |
|
1540
Chegg
CHGG
$167M
| $57.7K | ﹤0.01% |
90,264
+70,866
| +365% | +$45.3K |
|
1541
Erasca
ERAS
$443M
| $55.2K | ﹤0.01% |
+40,322
| New | +$55.2K |
|
1542
Vimeo
VMEO
$1.28B
| $54.7K | ﹤0.01% |
+10,393
| New | +$54.7K |
|
1543
Definitive Healthcare
DH
$432M
| $54.6K | ﹤0.01% |
18,890
+6,583
| +53% | +$19K |
|
1544
Stoneridge
SRI
$228M
| $54.1K | ﹤0.01% |
+11,788
| New | +$54.1K |
|
1545
Caribou Biosciences
CRBU
$168M
| $53.2K | ﹤0.01% |
+58,248
| New | +$53.2K |
|
1546
E.W. Scripps
SSP
$257M
| $52.9K | ﹤0.01% |
17,871
-2,406
| -12% | -$7.12K |
|
1547
GoodRx Holdings
GDRX
$1.46B
| $51.2K | ﹤0.01% |
+11,619
| New | +$51.2K |
|
1548
8x8 Inc
EGHT
$286M
| $49.8K | ﹤0.01% |
24,920
-6,897
| -22% | -$13.8K |
|
1549
Sutro Biopharma
STRO
$74.3M
| $48.8K | ﹤0.01% |
+75,066
| New | +$48.8K |
|
1550
Nuvation Bio
NUVB
$1.07B
| $48.3K | ﹤0.01% |
27,415
-9,578
| -26% | -$16.9K |
|